Hohe Auszeichnung für Mainzer Krebsforscher

Professor Ugur Sahin erhält den Deutschen Krebspreis 2019 Mainz, 28. Februar 2019 – Univ.-Prof. Dr. Ugur Sahin hat den Deutschen Krebspreis 2019 erhalten – eine der angesehensten Auszeichnungen in der Krebsmedizin in Deutschland. Prof. Sahin erhält den Preis in der Kategorie Transferforschung für seine wegweisenden Arbeiten zu individualisierten Krebsimmuntherapien, insbesondere für die Entwicklung und klinische

Continue Reading

At the top of the world with personalized cancer immunotherapy

Official foundation ceremony of HI-TRON Mainz Mainz, February 14, 2019 – The new Helmholtz Institute for Translational Oncology (HI-TRON Mainz) is to become one of the world’s leading centers for personalized cancer immunotherapy. This is the ambitious goal of the cooperation partners German Cancer Research Center (DKFZ) and the Research Institute Translational Oncology (TRON gGmbH)

Continue Reading

TRON celebrates young talent

Mainz, January 31, 2019 – TRON celebrates young talent TRON is sponsoring two scholarships in the Deutschlandstipendium 2018/2019 of the Johannes Gutenberg University Mainz, thereby supporting two young medical students as part of this Federal Ministry of Education and Research program. On January 31st, the festive dinner for Deutschlandstipendium sponsors and scholarship holders took place

Continue Reading

Ugur Sahin at 1st German Cancer Research Congress

Mainz, February 5, 2019 – The 1st German Cancer Research Congress (GCRC) is taking place in Heidelberg 4-5 February, showcasing the best cancer research in Germany.   Ugur Sahin will speak in the session on Tumor Immunology and Immunotherapy on Tuesday, February 5th.   For more information on this event, please see the official DKFZ website.

Continue Reading

Neoepitope specific T cells can be functionally irrelevant

Mainz, December, 2018 – TRON is proud to have taken part in the research that lead to this publication in OncoImmunology. This publication – in collaboration with scientists from BioNTech, DKFZ, JPT, and the University Medicine Mainz – points to hurdles on our way to highly personalized cancer immunotherapy. The research group investigated neoepitope-specific CD8+

Continue Reading

Actively personalized vaccination trial for newly diagnosed glioblastoma

Mainz, December 20, 2018 – TRON is delighted to announce an article published in Nature.   Working with GAPVAC (Glioma Actively Personalized Vaccine Consortium), TRON participated in developing a highly personalized approach to the treatment of glioblastoma. The consortium publish data on the results of a phase 1 multi-center, multi-national clinical trial, showing favorable safety

Continue Reading

TRON scientists are co-authors in a Nature Communications article

Mainz, December 6, 2018 – TRON scientists are co-authors in a Nature Communications article In collaboration with a scientists from Italy and Germany, TRON has co-authored an article on the induction of immunosuppressive functions in monocytes by c-FLIP, published in Nature Communications.  The data show that modulation of c-FLIP in monocytes may offer a path

Continue Reading

Nanomedicine and macroscale materials in immuno-oncology

Mainz, November 27, 2018 – TRON is delighted to announce an article published in Chemical Society Reviews co-authored by Mustafa Diken. In collaboration with a European team of scientists working on nanomaterials in medicine, Dr. Diken provides an overview of the current state-of-the-art concerning nano- and macroscale materials and their application in immunotherapy. Covering current

Continue Reading

Mustafa Diken gives a lecture at the EMDS conference in Verona

Verona, September 27, 2018 – The Macrophage and Dendritic Cell Society is holding its 32nd annual meeting 27-29 September in beautiful Verona, Italy. This year’s theme is “the crossroad between macrophage and dendritic cells: from immunometabolism to single cell fate.” In this context, TRON’s Mustafa Diken is giving today’s Happy Hour Lecture, entitled “Bringing the

Continue Reading